OsteoDenx capsules recall

OsteoDenx OsteoDenx capsules

U.S. Food and Drug Administration · Nov 13, 2026

Recall Kitchen watches public recall notices for products you track.

Save to my items

Saving creates a free account. We'll watch this product and show new matches in your account.

OsteoDenx® 30 capsules (17.85 g)OsteoDenx® 30 capsules (17.85 g)OsteoDenx® 30 capsules (17.85 g)OsteoDenx® 30 capsules (17.85 g)

BioQuad Life Sciences of Yorba Linda, California is recalling specific lots of the OsteoDenx® Dietary Supplement because they contain undeclared milk. The product contains lactoferrin derived from cow's milk, creating a risk of serious or life-threatening allergic reactions for individuals with milk allergies or severe sensitivities. The recalled items were distributed nationwide within the United States. Sales channels included online orders at bioquad.com and Amazon.com, various resellers, and a dental clinic located in Redwood City, California. The distribution period for these products ranged from November 1, 2024 to November 11, 2026. Distribution has ceased until corrected cartons are available. The recall affects OsteoDenx® capsules packaged in paperboard cartons of 30 or 60 capsules. The lot number and expiration date are printed on the side panel of the carton. Consumers who purchased the affected lots may request a full refund or a replacement in corrected packaging by contacting the company. The specific product configurations, UPCs, lot numbers, and expiration dates included in this recall are listed below. OsteoDenx® 30 capsules (17.85 g) UPC 8 57294 00722 8 LOT#0524100 Expiration 05/2027 OsteoDenx® 30 capsules (17.85 g) UPC 8 57294 00722 8 LOT#0625041 Expiration 08/2028 OsteoDenx® 60 capsules (35.7 g) UPC 8 57294 00734 1 LOT#0524100 Expiration 05/2027 OsteoDenx® 60 capsules (35.7 g) UPC 8 57294 00734 1 LOT#0625041 Expiration 08/2028 Customers with questions may contact the company at (714) 660-1031 or [email protected] Monday to Friday, 9:30 AM to 5:00 PM Pacific Time. No illnesses have been reported to date and the issue was identified during a routine FDA inspection.

Affected products

  • OsteoDenx® 30 capsules (17.85 g)
    UPC
    857294007228
    Use by
    05/2027, 08/2028
  • OsteoDenx® 60 capsules (35.7 g)
    UPC
    857294007341
    Use by
    05/2027, 08/2028

View original